Potent Activity of the Novel Combination Meropenem-pilabactam (Formerly ANT3310) Against Global OXA- and KPC-Carbapenem-Resistant Enterobacterales (CRE) Clinical Isolates from 2019 to 2023

Apr 27, 2026

C. Da Silva, A. Alary, M.I. Ancora, S. Hawser, M. Hackel, A. Ledoux, M. Lemonnier, M. Zalacain, A. Llanos